Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KN motif and ankyrin repeat domains 3 (KANK3) is a member of the KANK protein family, characterized by an N-terminal coiled-coil KN motif and C-terminal ankyrin repeat domains. KANK3 is predicted to regulate the polymerization of actin filaments, thus modulating cytoskeletal organization and cell motility; it acts mainly via negative regulation of actin stress fiber formation and inhibition of RhoA activity, similar to other KANK family proteins. KANK3 is expressed in the cytoplasm and cytoskeleton across multiple tissues. Mutations or dysregulation in KANK family genes are linked to diseases such as cancer and neurodevelopmental disorders, but KANK3 is not established as a therapeutic target nor are there drugs that directly act on it. If more detailed mechanistic or disease information becomes available, a reassessment of its therapeutic target status may be warranted.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KN motif and ankyrin repeat domains 3 (KANK3).